Loading clinical trials...

Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii | Clinical Trials | Clareo Health

UNKNOWNPHASE3

Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii

Phase 3b Randomized Double Blind Controled Placebo Comparative Trial of Intravenous Colistin vs Intravenous Colistin Plus Nebulized Colistin in Patients With Ventilator-associated Pneumonia (VAP) Due Multiresistant Acinetobacter Baumanii

NCT00645723•Hospitales Universitarios Virgen del Rocío

View on ClinicalTrials.gov

Summary

Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant.

Detailed Description

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Diagnose of VAP due A. baumannii or A. baumannii and another microorganism carbapenems resistant.
•Clinical Pulmonary Infection Score (CPIS) \> 6

Exclusion Criteria

•Allergy to colistin.
•Asthma
•Shock status
•Diagnose of VAP due A. baumannii colistin resistant.

Locations (1)

Hospital Universitario Virgen del Rocío

Seville, Seville, Spain

Key Dates

Start Date

April 1, 2008

Primary Completion Date

April 1, 2011

Completion Date

April 1, 2011

Last Updated

August 6, 2009

Enrollment

ESTIMATED participants

Conditions

Cross InfectionPneumonia, Bacterial

Interventions

Colistin

DRUG

Colistin and saline solution

DRUG

Contacts

José Garnacho, MD

CONTACT

34-95-501-2235 jose.garnacho.sspa@juntadeandalucia.es

Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients

NCT05976581

PneumoniaPneumonia, Viral+1 more

View study

NOT_YET_RECRUITING

Reuse of Polyp Traps, a Way to Approach Sustainability

NCT06838312

Cross Infection

View study

NOT_YET_RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 6, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii

Inclusion Criteria

Exclusion Criteria

Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients

Reuse of Polyp Traps, a Way to Approach Sustainability

" a Randomized Pilot Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation (ECMO-VA)."

CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study

Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection

Prevalence and Serotype of Streptococcus Pneumoniae Hospitalized Adult With Community-Acquired Pneumonia